Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

RNTX

Rein Therapeutics Inc

Nov 06 • 11:37AM ET

1.64

+0.05 3.14 %

Healthcare • Biotechnology • USA • NASD

Peers: BPMC MRNA AGEN FATE SRPT BLUE SGMO CYCN RXRX

| Held by: VTI VXF IWC ONEQ

Index	-	P/E	-	EPS (ttm)	-2.69	Insider Own	8.02%	Shs Outstand	23.05M	Perf Week	5.81%
Market Cap	38.62M	Forward P/E	-	EPS next Y	-0.81	Insider Trans	19.34%	Shs Float	21.66M	Perf Month	17.99%
Enterprise Value	77.91M	PEG	-	EPS next Q	-0.23	Inst Own	28.16%	Short Float	0.12%	Perf Quarter	47.75%
Income	-59.15M	P/S	-	EPS this Y	72.51%	Inst Trans	1.77%	Short Ratio	0.03	Perf Half Y	-4.65%
Sales	0.00M	P/B	12.57	EPS next Y	16.06%	ROA	-70.89%	Short Interest	0.03M	Perf YTD	-28.70%
Book/sh	0.13	P/C	6.75	EPS next 5Y	34.86%	ROE	-79.38%	52W High	3.99 -58.90%	Perf Year	-59.00%
Cash/sh	0.24	P/FCF	-	EPS past 3/5Y	15.90% 31.90%	ROIC	-123.20%	52W Low	1.04 57.69%	Perf 3Y	-60.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	20.98% 11.43%	Perf 5Y	-92.87%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	17.02%	Oper. Margin	-	ATR (14)	0.19	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.86	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	60.20	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.86	EPS Q/Q	37.19%	SMA20	17.25%	Beta	1.27	Target Price	8.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	26.62%	Rel Volume	0.61	Prev Close	1.59
Employees	11	LT Debt/Eq	0.00	Earnings	Aug 06	SMA200	-0.21%	Avg Volume	885.87K	Price	1.64
IPO	Jun 29, 2017	Option/Short	No / Yes	EPS/Sales Surpr.	-27.27% -	Trades		Volume	194,734	Change	3.14%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-22-25	Initiated	H.C. Wainwright	Buy	$10
Jan-28-25	Initiated	Rodman & Renshaw	Buy	$8
Jul-24-17	Initiated	William Blair	Outperform
Jul-24-17	Initiated	Jefferies	Buy	$20
Jul-24-17	Initiated	BofA/Merrill	Buy	$19

Today 07:30AM	Rein Therapeutics Announces New Scientific Publication Demonstrating LTI-03 May Reduce Lung Scarring and Protect Cells Needed for Lung Repair in IPF (GlobeNewswire)
Nov-03-25 07:30AM	Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (GlobeNewswire) +11.82%
Oct-09-25 07:30AM	Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (GlobeNewswire)
Sep-17-25 07:30AM	Rein Therapeutics Announces Publication of New Translational Data in iScience on Company's Novel Therapy for Idiopathic Pulmonary Fibrosis (GlobeNewswire)
Aug-19-25 09:32AM	Palo Alto upgraded, Li Auto downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	Loading…
08:00AM	Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (GlobeNewswire)
Aug-14-25 05:00PM	Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025 (GlobeNewswire)
Jul-30-25 08:30AM	Rein Therapeutics Enters into Agreements for up to $21 Million in Flexible Financing (GlobeNewswire)
Jun-24-25 10:11AM	Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders (PR Newswire)
May-27-25 07:00AM	Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF (PR Newswire)
May-19-25 04:51PM	Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference (PR Newswire) -10.23%
May-15-25 04:09PM	Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update (PR Newswire) -6.36%
May-12-25 07:00AM	Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF (PR Newswire)
May-01-25 07:00AM	Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF (PR Newswire)
Apr-30-25 04:05PM	Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025 (PR Newswire)
07:00AM	Loading…
Apr-28-25 07:00AM	Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference (PR Newswire) -7.85%
Apr-23-25 07:00AM	Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases (PR Newswire)
Apr-15-25 07:00AM	Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F (PR Newswire)
Apr-07-25 04:17PM	Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (PR Newswire) -15.24%
Jan-10-25 11:30AM	Aileron Therapeutics Announces Rebranding to Rein Therapeutics (PR Newswire) +9.33%
Nov-14-24 04:15PM	Aileron Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights (PR Newswire) -7.28% -13.29%
Nov-13-24 01:04PM	Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis (Benzinga) -6.79%
07:00AM	Aileron Therapeutics Announces Positive Topline Data from Cohort 2 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) (PR Newswire)
Oct-31-24 07:30AM	Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma (PR Newswire) +7.01%
Oct-12-24 09:00AM	Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lung and Airway Fibrosis (PR Newswire)
Sep-23-24 07:30AM	Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) (PR Newswire)
Aug-19-24 04:05PM	Aileron Therapeutics to Present at the 8th Annual IPF Summit (PR Newswire) +13.76% +11.63%
Aug-14-24 06:05PM	Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights (PR Newswire) -10.19% -10.81%
Jul-30-24 08:00AM	Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference (PR Newswire)
Jul-01-24 08:00AM	Aileron Therapeutics to be Included in the Russell Microcap Index (PR Newswire)
10:53PM	Loading…
May-15-24 10:53PM	ALRN Stock Earnings: Aileron Therapeutics Reported Results for Q1 2024 (InvestorPlace)
05:13PM	Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
May-07-24 09:35AM	Down -36.29% in 4 Weeks, Here's Why Aileron Therapeutics (ALRN) Looks Ripe for a Turnaround (Zacks) -6.58%
May-06-24 04:05PM	Aileron Therapeutics to Present at Two Upcoming Investor Conferences (GlobeNewswire) +5.05%
May-03-24 04:33PM	Aileron Therapeutics Closes Direct Offering of Shares, Warrants (MT Newswires)
04:05PM	Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million (GlobeNewswire)
May-02-24 07:24AM	Aileron reports data from cohort one of Phase Ib inhaled IPF treatment trial (Clinical Trials Arena) -8.17%
May-01-24 08:45AM	Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million (GlobeNewswire) -8.57%
08:30AM	Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) (GlobeNewswire)
Apr-16-24 09:52AM	ALRN Stock Earnings: Aileron Therapeutics Reported Results for Q4 2023 (InvestorPlace) -9.78%
Apr-15-24 05:20PM	Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-12-24 08:00AM	Aileron Therapeutics Announces CEO Transition (GlobeNewswire) -5.41%
Feb-15-24 04:05PM	Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event (GlobeNewswire)
Feb-01-24 04:30PM	Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024 (GlobeNewswire) -6.06% +13.44%
Oct-31-23 12:30PM	Aileron Therapeutics Announces Acquisition of Lung Therapeutics (PR Newswire)
Apr-04-23 09:55AM	Bears are Losing Control Over Aileron Therapeutics, Inc. (ALRN), Here's Why It's a 'Buy' Now (Zacks)
Mar-14-23 09:55AM	Aileron Therapeutics, Inc. (ALRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now (Zacks) +12.12%
Feb-22-23 11:49AM	Cancer drugmaker down to 3 employees after trial failure (American City Business Journals) +6.16%
Feb-21-23 02:50PM	Aileron Therapeutics Shelves Development On Chemoprotection Agent, Shares Fall (Benzinga) -37.77%
08:30AM	Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives (GlobeNewswire)
Dec-29-22 12:00PM	What Makes Aileron Therapeutics, Inc. (ALRN) a New Buy Stock (Zacks)
Nov-30-22 07:00AM	Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Nov-24-22 09:55AM	Aileron Therapeutics, Inc. (ALRN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
Nov-10-22 08:00AM	Aileron Therapeutics Announces a 1-for-20 Reverse Stock Split (GlobeNewswire) -11.98%
Nov-04-22 12:00PM	Aileron Therapeutics, Inc. (ALRN) Moves to Buy: Rationale Behind the Upgrade (Zacks) +10.94%
Nov-01-22 08:15AM	Aileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights (GlobeNewswire)
Oct-26-22 06:05AM	Aileron Therapeutics Presents Results from Phase 1 Study in Healthy Volunteers Demonstrating ALRN-6924 Induced Cell Cycle Arrest in Bone Marrow Stem Cells and Hair Follicles at EORTC-NCI-AACR International Conference (GlobeNewswire) -5.83%
Sep-30-22 08:41AM	Aileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at the European Society for Dermatological Research Annual Meeting 2022 (GlobeNewswire) -8.13%
Sep-22-22 08:00AM	Aileron Therapeutics to Present and Participate in a Fireside Chat at the Ladenburg Thalmann 2022 Healthcare Conference (GlobeNewswire)
Sep-06-22 07:00AM	Aileron Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-15-22 04:15PM	Aileron Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights (GlobeNewswire)
Aug-01-22 07:51AM	Aileron Therapeutics Is Pleased to Outline Strategy to Strengthen Phase 1b Clinical Trial of ALRN-6924 in Patients with p53-Mutated Breast Cancer (GlobeNewswire) -15.68%
Jul-08-22 08:31AM	Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2022 (GlobeNewswire)
Jun-29-22 09:46AM	Aileron Shares Fall After Early Data From Chemoprotective Agent In Lung Cancer Setting (Benzinga) -27.14%
06:30AM	Aileron Therapeutics Announces Interim Data from Phase 1b Chemoprotection Trial of ALRN-6924 in Patients with p53-Mutated Non-Small Cell Lung Cancer (NSCLC) and Confirms Development Path for ALRN-6924 Focused on p53-Mutated Breast Cancer (GlobeNewswire)
May-19-22 07:00AM	Aileron Therapeutics Announces First Patients Treated in Phase 1b Trial of ALRN-6924 in Patients with p53-Mutated Neoadjuvant Breast Cancer (GlobeNewswire)
06:40AM	3 Oversold Biotech Stocks to Buy Now (InvestorPlace)
May-17-22 07:00AM	Aileron Therapeutics to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire) +12.92%
May-13-22 07:00AM	Aileron Therapeutics to Host Virtual KOL Investor Event on May 19, 2022 (GlobeNewswire) +9.15%
May-11-22 07:57AM	Will Aileron Therapeutics (NASDAQ:ALRN) Spend Its Cash Wisely? (Simply Wall St.)
May-10-22 12:43PM	Aileron Therapeutics Announces Late-Breaking Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at Upcoming Society for Investigative Dermatology 2022 Annual Meeting (GlobeNewswire)
May-05-22 04:15PM	Aileron Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights (GlobeNewswire)
Apr-21-22 09:40AM	Is Aileron Therapeutics (ALRN) Outperforming Other Medical Stocks This Year? (Zacks) -6.12%
08:00AM	Aileron Expands Management Team with Appointment of Christopher Zergebel As Vice President, Program Management and Clinical Operations (GlobeNewswire)
Apr-05-22 09:40AM	Is Aileron Therapeutics, Inc. (ALRN) Stock Outpacing Its Medical Peers This Year? (Zacks) +5.88%
Mar-28-22 04:20PM	Aileron Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights (GlobeNewswire) -7.41%
Mar-22-22 08:04AM	Aileron Therapeutics to Participate in Maxim Group 2022 Virtual Growth Conference (GlobeNewswire)
Jan-27-22 01:38PM	Morgan Jess S & Co Inc Buys Wells Fargo, PowerShares QQQ Trust Ser 1, NVIDIA Corp, Sells ... (GuruFocus.com) -9.48%
Jan-05-22 08:04AM	Aileron Therapeutics Provides Business Update and Outlines 2022 Strategic Priorities to Deliver Key Milestones (GlobeNewswire) -7.27%
Jan-04-22 08:45AM	Aileron Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
07:00AM	CEO Presenting on the Emerging Growth Conference on January 5 Register Now (GlobeNewswire)
Dec-30-21 04:32AM	As Aileron Therapeutics, Inc.'s market cap (NASDAQ:ALRN) drops to US$47m, insiders might be questioning their decision to buy earlier this year (Simply Wall St.)
Dec-20-21 10:56AM	Aileron Therapeutics Issues Statement on Passing of Scientific Advisory Board Member and Nobel Laureate Robert H. Grubbs (GlobeNewswire)
Nov-12-21 07:50AM	Aileron Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights (GlobeNewswire) -6.13%
Oct-07-21 09:22AM	Aileron Therapeutics Presents Data at AACR-NCI-EORTC International Conference Demonstrating ALRN-6924s Activity as Radioprotective Agent in Preclinical Models of Acute Radiation-Induced Toxicity (GlobeNewswire)
Sep-30-21 04:30PM	Aileron Therapeutics Announces Presentation of New Preclinical Data at Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021 (GlobeNewswire)
Sep-16-21 02:33PM	Aileron Stock Is Trading Lower After Data Presentation For Chemoprotective Agent (Benzinga) -6.09%
08:15AM	Aileron Therapeutics Presents New Clinical Data at ESMO Virtual Congress 2021 Supporting ALRN-6924s Best-in-Class Potential as a Chemoprotective Agent (GlobeNewswire)
Sep-10-21 08:30AM	Aileron Therapeutics to Present New Clinical Data at ESMO Virtual Congress 2021 Supporting Novel, Selective Chemoprotective Agent ALRN-6924 (GlobeNewswire) +6.72%
Sep-07-21 04:05PM	Aileron Therapeutics to Present at Upcoming H.C. Wainwright Virtual Global Investment Conference (GlobeNewswire)
Aug-27-21 09:48AM	Aileron Unveils Initial Data For Its Chemo Protective Agent (Benzinga)
07:45AM	Aileron Therapeutics Presents Initial Findings from Ongoing Healthy Volunteer Study of ALRN-6924 at ISEH 50th Annual Scientific Meeting (GlobeNewswire)
Aug-11-21 04:20PM	Aileron Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire) +8.00%
Jul-08-21 08:15AM	Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021 (GlobeNewswire)
Jul-01-21 01:39PM	Aileron Launches Early-Stage Study For Chemoprotective Candidate In Lung Cancer Settings (Benzinga)
08:00AM	Aileron Therapeutics Announces Initiation of Randomized, Double-Blind, Placebo-Controlled Trial of ALRN-6924 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) (GlobeNewswire)
Jun-30-21 09:33AM	Hedge Funds Are Betting On Aileron Therapeutics, Inc. (ALRN) (Insider Monkey) -6.02%
Jun-24-21 07:00AM	Aileron Therapeutics to be Added to the Russell Microcap® Index (GlobeNewswire) +8.66%
May-19-21 07:00AM	Aileron Therapeutics to Host KOL Virtual Investor Event Discussing Opportunity for New Paradigm to Protect Cancer Patients from Chemotherapy-Induced Toxicities (GlobeNewswire)
May-11-21 04:18PM	Aileron Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire)

Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky on August 6, 2001 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Voss Capital, LP	10% Owner	Oct 28 '25	Buy	1.39	178,392	247,965	500,000	Oct 28 06:45 PM
Voss Capital, LP	10% Owner	Oct 27 '25	Buy	1.37	97,482	133,544	822,258	Oct 28 06:45 PM
Voss Capital, LP	10% Owner	Oct 24 '25	Buy	1.39	30,176	41,957	729,616	Oct 28 06:45 PM
WINDSOR JAMES BRIAN	President and CEO	Dec 05 '24	Buy	2.24	400	898	239	Dec 09 04:09 PM

ALTG Alta Equipment Group Inc daily Stock Chart

Peers: URI HEES TITN MGRC TEX MTW CAT DE CMCO OSK

| Held by: VTI IWM VXF DES IWN VTWO DFAS AVUV DFAC AVSC

Index	RUT	P/E	-	EPS (ttm)	-2.06	Insider Own	38.64%	Shs Outstand	32.05M	Perf Week	-1.01%
Market Cap	188.43M	Forward P/E	-	EPS next Y	-0.62	Insider Trans	0.08%	Shs Float	19.67M	Perf Month	-12.76%
Enterprise Value	1.37B	PEG	-	EPS next Q	-0.20	Inst Own	53.30%	Short Float	4.55%	Perf Quarter	-24.03%
Income	-68.30M	P/S	0.10	EPS this Y	7.66%	Inst Trans	-3.60%	Short Ratio	4.24	Perf Half Y	31.25%
Sales	1.85B	P/B	4.29	EPS next Y	39.71%	ROA	-4.31%	Short Interest	0.90M	Perf YTD	-10.09%
Book/sh	1.37	P/C	14.28	EPS next 5Y	-	ROE	-77.23%	52W High	8.99 -34.60%	Perf Year	-11.85%
Cash/sh	0.41	P/FCF	2.76	EPS past 3/5Y	-38.53% 16.55%	ROIC	-7.77%	52W Low	3.54 66.10%	Perf 3Y	-53.59%
Dividend Est.	-	EV/EBITDA	8.44	Sales past 3/5Y	15.66% 27.48%	Gross Margin	24.25%	Volatility	3.17% 4.16%	Perf 5Y	-22.84%
Dividend TTM	0.17 (2.91%)	EV/Sales	0.74	EPS Y/Y TTM	-222.37%	Oper. Margin	1.21%	ATR (14)	0.27	Perf 10Y	-
Dividend Ex-Date	May 15, 2025	Quick Ratio	0.48	Sales Y/Y TTM	-3.46%	Profit Margin	-3.69%	RSI (14)	37.49	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.39	EPS Q/Q	45.66%	SMA20	-5.95%	Beta	1.53	Target Price	11.38
Payout	-	Debt/Eq	27.13	Sales Q/Q	-1.41%	SMA50	-15.60%	Rel Volume	0.39	Prev Close	6.07
Employees	2900	LT Debt/Eq	19.03	Earnings	Nov 06 AMC	SMA200	-7.25%	Avg Volume	211.46K	Price	5.88
IPO	Apr 25, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	33.28% 0.53%	Trades		Volume	29,971	Change	-3.13%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-18-25	Downgrade	DA Davidson	Buy → Neutral	$8
Jul-08-25	Upgrade	Northland Capital	Market Perform → Outperform	$20
Mar-27-25	Resumed	B. Riley Securities	Buy	$10
Nov-13-24	Downgrade	Northland Capital	Outperform → Market Perform	$20
Sep-23-22	Initiated	Northland Capital	Outperform	$25
Jan-04-22	Reiterated	B. Riley Securities	Buy	$21 → $22
May-14-21	Upgrade	Raymond James	Mkt Perform → Outperform	$12.50 → $16
Apr-07-20	Initiated	Dougherty & Company	Buy	$8.50

Nov-05-25 08:10AM	Trimble Navigation (TRMB) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Nov-04-25 10:28PM	Alta Earnings: What To Look For From ALTG (StockStory)
Oct-30-25 06:10PM	Standex International (SXI) Q1 Earnings Surpass Estimates (Zacks)
07:00AM	Alta Equipment Group Announces Date of Third Quarter 2025 Financial Results Release, Conference Call and Webcast (GlobeNewswire)
Oct-29-25 08:10AM	Oshkosh (OSK) Tops Q3 Earnings Estimates (Zacks)
07:40AM	Loading…
Oct-28-25 07:40AM	Applied Industrial Technologies (AIT) Q1 Earnings and Revenues Surpass Estimates (Zacks)
Oct-17-25 01:50PM	Why Alta (ALTG) Shares Are Sliding Today (StockStory)
Oct-03-25 07:00AM	Alta Equipment Group Announces Preferred Stock Dividend (GlobeNewswire)
Sep-22-25 11:34PM	A Look Back at Specialty Equipment Distributors Stocks' Q2 Earnings: Alta (NYSE:ALTG) Vs The Rest Of The Pack (StockStory) +5.36%
Sep-19-25 12:04AM	3 Reasons to Sell ALTG and 1 Stock to Buy Instead (StockStory)
Sep-18-25 12:38AM	1 Industrials Stock for Long-Term Investors and 2 We Brush Off (StockStory)
Sep-17-25 12:37AM	3 Profitable Stocks We Approach with Caution (StockStory)
Aug-18-25 09:33AM	CVS Health upgraded, Occidental downgraded: Wall Street's top analyst calls (The Fly)
Aug-14-25 01:43AM	5 Insightful Analyst Questions From Alta's Q2 Earnings Call (StockStory)
Aug-08-25 05:20AM	Alta (NYSE:ALTG) Surprises With Q2 Sales (StockStory) +7.95%
03:40AM	Loading…
03:40AM	Alta Equipment Group Inc (ALTG) Q2 2025 Earnings Call Highlights: Resilient Performance Amid ... (GuruFocus.com)
Aug-07-25 05:55PM	Alta Equipment (ALTG) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:52PM	Alta Equipment: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Alta Equipment Group Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-05-25 11:17PM	What To Expect From Alta's (ALTG) Q2 Earnings (StockStory)
06:45PM	Regal Rexnord (RRX) Tops Q2 Earnings and Revenue Estimates (Zacks)
Jul-30-25 08:15AM	Idex (IEX) Q2 Earnings and Revenues Beat Estimates (Zacks)
Jul-28-25 04:15PM	Alta Equipment Group Announces Date of Second Quarter 2025 Financial Results Release, Conference Call and Webcast (GlobeNewswire) -5.45%
Jul-09-25 09:15AM	Alta Equipment (ALTG) Stock Jumps 16.1%: Will It Continue to Soar? (Zacks)
Jul-02-25 07:00AM	Alta Equipment Group Announces Preferred Stock Dividend (GlobeNewswire) +8.33%
Jun-26-25 11:35PM	Specialty Equipment Distributors Stocks Q1 Highlights: Alta (NYSE:ALTG) (StockStory)
Jun-19-25 12:31AM	3 Russell 2000 Stocks Walking a Fine Line (StockStory)
Jun-18-25 12:06AM	Alta (ALTG): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jun-16-25 07:34AM	Zacks.com featured highlights include BrightSpring Health Services, Allegiant Travel, CVR Energy, Alta Equipment Group and Cracker Barrel Old Country Store (Zacks)
Jun-13-25 11:19AM	5 Broker-Favored Stocks to Watch Amid Cooling Inflation (Zacks)
09:41AM	Loading…
Jun-11-25 09:41AM	ALTG Q1 Earnings Call: Portfolio Reshaping and Margin Focus Amid Revenue Decline (StockStory)
May-27-25 12:33AM	3 Profitable Stocks with Red Flags (StockStory) +6.53%
May-08-25 03:37AM	Alta Equipment Group Inc (ALTG) Q1 2025 Earnings Call Highlights: Strategic Divestitures and ... (GuruFocus.com)
May-07-25 05:50PM	Alta Equipment (ALTG) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:44PM	Alta Equipment: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Alta Equipment Group Announces First Quarter 2025 Financial Results, Reaffirms Organic Guidance post-Business Divestiture, and Introduces Rebalancing in Capital Allocation Strategy (GlobeNewswire)
May-06-25 06:35PM	Vestis (VSTS) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
May-02-25 07:00AM	Alta Equipment Group Announces Common Stock Dividend (GlobeNewswire) +6.03%
Apr-23-25 04:15PM	Alta Equipment Group Announces Date of First Quarter 2025 Financial Results Release, Conference Call and Webcast (GlobeNewswire) +6.10%
Apr-10-25 07:36AM	Parker-Hannifin (PH) Soars 13.4%: Is Further Upside Left in the Stock? (Zacks) -5.31%
Apr-07-25 05:07AM	Specialty Equipment Distributors Stocks Q4 In Review: Alta (NYSE:ALTG) Vs Peers (StockStory)
Apr-03-25 07:00AM	Alta Equipment Group Announces Preferred Stock Dividend (GlobeNewswire) -16.77%
Mar-31-25 01:00PM	Alta Equipment Group Names Jonathan Hesener President of Material Handling (ACCESSWIRE)
Mar-24-25 05:11AM	3 Reasons to Sell ALTG and 1 Stock to Buy Instead (StockStory)
Mar-20-25 06:28PM	Alta Equipment Group Inc. (ALTG): A Bull Case Theory (InsiderMonkey) -5.83%
Mar-11-25 10:01AM	Alta Equipment price target lowered to $8.50 from $9 at Raymond James (TipRanks) +6.51%
Mar-06-25 01:14PM	Q4 2024 Alta Equipment Group Inc Earnings Call (Thomson Reuters StreetEvents)
02:13AM	Alta Equipment Group Inc (ALTG) Q4 2024 Earnings Call Highlights: Navigating Market Challenges ... (GuruFocus.com)
Mar-05-25 04:44PM	Alta Equipment: Q4 Earnings Snapshot (Associated Press Finance) +7.14%
04:30PM	Altas (NYSE:ALTG) Q4 Sales Beat Estimates (StockStory)
04:15PM	Alta Equipment Group Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Adjusted EBITDA Guidance for 2025 (GlobeNewswire)
Mar-04-25 08:05AM	What To Expect From Altas (ALTG) Q4 Earnings (StockStory) -8.46%
07:23AM	Earnings To Watch: Alta Equipment Group Inc (ALTG) Reports Q4 2024 Result (GuruFocus.com)
Feb-21-25 04:15PM	Alta Equipment Group Announces Date of Fourth Quarter and Full Year 2024 Financial Results Release, Conference Call and Webcast (GlobeNewswire) -6.25% -8.99%
Feb-03-25 07:00AM	Alta Equipment Group Announces Common Stock Dividend (GlobeNewswire) -5.75%
Jan-21-25 04:09AM	3 Reasons to Sell ALTG and 1 Stock to Buy Instead (StockStory)
Jan-03-25 07:00AM	Alta Equipment Group Announces Preferred Stock Dividend (GlobeNewswire)
Jan-02-25 04:07AM	Reflecting On Specialty Equipment Distributors Stocks Q3 Earnings: Alta (NYSE:ALTG) (StockStory)
04:04AM	Industrial Distributors Stocks Q3 Results: Benchmarking Beacon Roofing Supply (NASDAQ:BECN) (StockStory)
Dec-24-24 09:50AM	Is Billion Dollar Hedge Fund Voss Capital Crazy About Alta Equipment Group (ALTG)? (Insider Monkey)
04:08AM	Q3 Earnings Roundup: Herc (NYSE:HRI) And The Rest Of The Specialty Equipment Distributors Segment (StockStory)
Dec-10-24 05:10AM	Q3 Earnings Highlights: GMS (NYSE:GMS) Vs The Rest Of The Industrial Distributors Stocks (StockStory)
Dec-05-24 01:44AM	Specialty Equipment Distributors Stocks Q3 Results: Benchmarking SiteOne (NYSE:SITE) (StockStory)
Dec-02-24 06:29AM	Specialty Equipment Distributors Stocks Q3 Recap: Benchmarking H&E Equipment Services (NASDAQ:HEES) (StockStory)
Nov-17-24 04:49PM	Alta Equipment Group Inc. (ALTG): A Bull Case Theory (Insider Monkey)
Nov-13-24 02:22AM	Alta Equipment Group Inc (ALTG) Q3 2024 Earnings Call Highlights: Strategic Deleveraging and ... (GuruFocus.com)
Nov-12-24 05:19PM	Alta Equipment: Q3 Earnings Snapshot (Associated Press Finance) -5.56%
04:26PM	Alta (NYSE:ALTG) Misses Q3 Sales Targets, Stock Drops 15.9% (StockStory)
04:15PM	Alta Equipment Group Announces Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 02:03AM	Alta (ALTG) Q3 Earnings: What To Expect (StockStory) +6.95%
Nov-07-24 04:15PM	Alta Equipment Group Announces Date of Third Quarter 2024 Financial Results Release, Conference Call and Webcast (GlobeNewswire) +6.10%
08:30AM	Alta Equipment (ALTG) Moves 15.8% Higher: Will This Strength Last? (Zacks)
Nov-04-24 07:00AM	Alta Equipment Group Announces Common Stock Dividend (GlobeNewswire)
Oct-04-24 05:42AM	Reflecting On Specialty Equipment Distributors Stocks Q2 Earnings: Richardson Electronics (NASDAQ:RELL) (StockStory)
Oct-03-24 07:00AM	Alta Equipment Group Announces Preferred Stock Dividend (GlobeNewswire)
Sep-06-24 03:48AM	Unpacking Q2 Earnings: Alta (NYSE:ALTG) In The Context Of Other Specialty Equipment Distributors Stocks (StockStory) -8.28%
Sep-04-24 07:00AM	Alta Equipment Group Elects Colin Wilson as Director (GlobeNewswire)
Aug-07-24 07:02PM	Alta Equipment: Q2 Earnings Snapshot (Associated Press Finance) -6.29% -21.73%
04:15PM	Alta Equipment Group Announces Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-06-24 03:12AM	Alta (ALTG) Q2 Earnings: What To Expect (StockStory)
Aug-02-24 04:46PM	Appian, Bitfarms, Diebold Nixdorf, and More Stocks See Action From Activist Investors (Barrons.com) -10.58%
07:00AM	Alta Equipment Group Announces Common Stock Dividend (GlobeNewswire)
Jul-24-24 07:00AM	Alta Equipment Group Announces Date of Second Quarter 2024 Financial Results Release, Conference Call and Webcast (GlobeNewswire)
Jul-05-24 06:19AM	Hudson Technologies (NASDAQ:HDSN): Strongest Q1 Results from the Specialty Equipment Distributors Group (StockStory)
Jul-04-24 07:43AM	Specialty Equipment Distributors Stocks Q1 Recap: Benchmarking Alta (NYSE:ALTG) (StockStory)
Jul-03-24 07:00AM	Alta Equipment Group Announces Preferred Stock Dividend (GlobeNewswire)
Jul-02-24 08:46AM	Do Options Traders Know Something About Alta Equipment (ALTG) Stock We Don't? (Zacks)
Jun-03-24 10:14AM	Here's Why Alta Equipment Group (ALTG) Stock Has Fallen ~30% (Insider Monkey) -5.69%
May-23-24 08:38AM	Is the Options Market Predicting a Spike in Alta Equipment (ALTG) Stock? (Zacks) -5.31%
May-21-24 06:30PM	Alta Equipment Group Announces Pricing of Private Offering of $500 Million of Senior Secured Second Lien Notes due 2029 (GlobeNewswire) -6.16%
09:44AM	DA Davidson Adjusts Alta Equipment Group Price Target to $20 From $22, Maintains Buy Rating (MT Newswires)
May-20-24 08:17AM	Alta Equipment Group Plans $500 Million Private Offering of Senior Secured Second Lien Notes (MT Newswires) +7.56%
07:35AM	Alta Equipment Group Announces Proposed Private Offering of $500 Million of Senior Secured Second Lien Notes (GlobeNewswire)
May-13-24 11:32AM	Alta Equipment Group Inc. (NYSE:ALTG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 03:16PM	Alta Equipment Group Inc. (ALTG) Q1 2024 Earnings: Misses EPS Estimates Amid Seasonal Challenges (GuruFocus.com) -9.79%
May-09-24 10:53AM	Q1 2024 Alta Equipment Group Inc Earnings Call (Thomson Reuters StreetEvents) -15.36%
04:01AM	Alta Equipment Group Inc (ALTG) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-08-24 06:30PM	Alta Equipment (ALTG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:32PM	Alta Equipment: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Alta Equipment Group Announces First Quarter 2024 Financial Results (GlobeNewswire)

Alta Equipment Group, Inc. engages in the operation of equipment dealership platforms. It operates through the following segments: Material Handling, Construction Equipment, Master Distribution and Corporate. The Material Handling segment includes the sale, service, and rental of lift trucks and other material handling equipment in Michigan, Illinois, Indiana, and New York. The Construction Equipment segment focuses on the selling, servicing, and rental of construction equipment in Michigan, Illinois, and Florida. The Master Distribution segment is principally engaged in large-scale equipment distribution with sub dealers throughout North America related to environmental processing equipment. The Corporate segment retains various unallocated expense items at the general corporate level. The company was founded in 1984 and is headquartered in Livonia, MI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
STUDDERT ANDREW P	Director	May 29 '25	Buy	4.80	6,743	32,348	93,334	Jun 02 06:26 PM
STUDDERT ANDREW P	Director	May 30 '25	Buy	4.80	3,257	15,650	96,591	Jun 02 06:26 PM
Brubaker Craig	Chief Operating Officer	Mar 05 '25	Sale	5.00	5,294	26,471	98,640	Mar 06 09:21 PM

RNTX

Rein Therapeutics Inc

ALTG

Alta Equipment Group Inc

Upgrade your FINVIZ experience